ExploreWatchlistsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Revenue

KYORIN Pharmaceutical Co., Ltd. (4569)

Market cap
¥106B
P/E ratio
19.6x
Kyorin Pharmaceutical manufactures and sells pharmaceutical products through an integrated system spanning from production to sales across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 2025130,087+8.83%
Mar 31, 2024119,532+5.53%
Mar 31, 2023113,270+7.33%
Mar 31, 2022105,534+2.56%
Mar 31, 2021102,904-6.44%
Mar 31, 2020109,983-3.20%
Mar 31, 2019113,620+2.69%
Mar 31, 2018110,640-4.10%
Mar 31, 2017115,373-3.44%
Mar 31, 2016119,483+5.62%
Mar 31, 2015113,121+1.54%
Mar 31, 2014111,400+4.08%
Mar 31, 2013107,031+3.68%
Mar 31, 2012103,232

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat